News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Industry Trends

>
  • IR Licensing and Partnerships

Latest News

Regeneron Acquires 23andMe for $256 Million in Bankruptcy Deal
Regeneron Acquires 23andMe for $256 Million in Bankruptcy Deal
By Don Tracy, Associate Editor

May 19th 2025

Deal includes 23andMe’s Biobank, Personal Genome Service, Total Health, and research services operations.

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
By Don Tracy, Associate Editor

May 16th 2025

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in its strategic plans amid recent market challenges.

Earned Media and ASCO: Provide Context Beyond the Data
Earned Media and ASCO: Provide Context Beyond the Data
By Michael Christel

May 13th 2025

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.

GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
By Don Tracy, Associate Editor

May 13th 2025

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society of Health-System Pharmacists, who warns of tariff-driven supply chain threats and continued growth in clinic drug costs.

Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
By Don Tracy, Associate Editor

April 28th 2025

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on high-impact innovations.

More News


Site Logo

Supporting Successful Pharma Leadership with Neuroscience-Based Learning

Beth Doladee and Neelima Paranjpey
September 29th 2020

To effectively lead in today’s unpredictable environment, several major pharma companies are turning to a neuroscience-based learning approach to leadership development.


Planning Ahead for a Post COVID-19 Workforce and Workplace

Planning Ahead for a Post COVID-19 Workforce and Workplace

Michael Wong
September 20th 2020

Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.


Site Logo

COVID-19 Vaccine Concerns Prompt Clinical Trial Transparency

Jill Wechsler, Pharm Exec’s Washington Correspondent
September 20th 2020

With all eyes on efforts to research and test potential vaccines and therapies to combat the coronavirus pandemic, fears about overly accelerated development programs has heightened demands for wider access to information on study protocols, statistical analysis plans, and early results.


Site Logo

COVID Causes Pharma Marketers to Watch TV

Elaine Quilici
September 14th 2020

Site Logo

Trump Escalates Drug Pricing War

Jill Wechsler, Pharm Exec’s Washington Correspondent
September 13th 2020

President Trump has taken on the pharma industry in a surprise move making significant cuts in reimbursement for drugs covered by Medicare.


Staying the Course in Product Launch

Staying the Course in Product Launch

Tom McDonnell
September 11th 2020

Amid pandemic, rely on the fundamentals.


Taking Biopharma’s Pulse in a Tough 2020

Taking Biopharma’s Pulse in a Tough 2020

Peter Young
September 11th 2020

Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead.


Site Logo

The Cultural Deficit in the Pharma Industry in the Era of COVID-19

Sheila Thorne
September 10th 2020

Multicultural campaigns crafted for diverse populations are insufficiently funded and do not receive the same support as mainstream campaigns, writes Sheila Thorne. While there are plenty of people willing to partner with pharma on these campaigns, will the industry wake up to the changing world ahead?


Site Logo

Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the Job

Wolfram Lux and Simone Seiter
September 8th 2020

Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug


Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

Pharmaceutical Executive Editors
September 8th 2020

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.


Site Logo

The Teladoc-Livongo Merger: Life Science Manufacturers’ Darwinian Moment

Vijesh Unnikrishnan and Ganesh Vedarajan
September 8th 2020

The recent merger of Teledoc and Livongo into a $38 billion titan proves that the market sees opportunity in health tech. Could it be an inflection point in our race towards a digital-first care model, or is this an experiment ahead of its time?


The Pharma Supply Chain Post-COVID-19: Key Lessons and Opportunities

The Pharma Supply Chain Post-COVID-19: Key Lessons and Opportunities

Ferdi Steinmann
August 31st 2020

Ferdi Steinmann outlines a few supply chain lessons that all pharma companies can learn from the COVID-19 pandemic.


Site Logo

Don’t Waste A Crisis: How Paratek is Navigating the Business Implications of the COVID-19 Pandemic

Evan Loh, M.D.;Jonathan Light
August 31st 2020

A look at how pharmaceutical company, Paratek is navigating the launch of a new antibiotic during the COVID-19 pandemic.


Rebel Talent: Why It Pays to Break the Rules When the Unemployment Rate is High

Rebel Talent: Why It Pays to Break the Rules When the Unemployment Rate is High

August 27th 2020

Michael Wong talks with Dr. Francesca Gino, Tandon Family Professor of Business Administration at the Harvard Business School, about the advantages of embracing a "rebel mindset."


How Pharma Reps and Managers Can Work to Overcome the In-Person HCP Barrier

How Pharma Reps and Managers Can Work to Overcome the In-Person HCP Barrier

C. Lee Smith
August 19th 2020

While HCPs are turning away from in-person meetings with sales reps amidst the COVID-19 pandemic, there are still strategies for them to keep their pipelines full.


How Copay Management by Payers Is Evolving

How Copay Management by Payers Is Evolving

Jeremy Schafer
August 18th 2020

A look into the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.


The Impact of Accelerated Drug Development

The Impact of Accelerated Drug Development

Manuel Hermosilla, PhD
August 18th 2020

Dr. Manuel Hermosilla shares his thoughts on how the pharmaceutical industry reacts to challenges that arise during trials, specifically during the search for an effective COVID-19 vaccine.


Revamping Internship Programs for a Virtual World

Revamping Internship Programs for a Virtual World

Rebecca Cenni-Leventhal
August 14th 2020

A look at how internship programs in the pharma industry have changed since the start of the COVID-19 pandemic.


Expanding Access to CAR-T: Dr. Greg Frost

Expanding Access to CAR-T: Dr. Greg Frost

Julian Upton
August 10th 2020

EXUMA Biotech's Dr. Greg Frost talks about his work making CAR-T cell therapy readily accessible and affordable.


HCPs & Virtual Meetings: What We Learned

HCPs & Virtual Meetings: What We Learned

Nate Wible ;Dan Donovan
August 10th 2020

Addressing the challenges created by virtual meetings with HCPs, what we have learned about virtual meetings so far, and a look into the future.


Site Logo

Strategic Realignment for a Better Future 1

Ben van der Schaaf;Aurelien Guichard
August 10th 2020

In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.


Tackling a ‘Genius Virus’

Tackling a ‘Genius Virus’

Julian Upton
August 10th 2020

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.


Site Logo

The New Data Dynamic: How COVID-19 has Upended Model

Julian Upton
August 10th 2020

While exposing gaps in the way pharma acquires and uses data, the pandemic has also fostered a new spirit of information sharing that bodes well for future collaborations.


Site Logo

How COVID-19 Has Affected Launches of New Oncology Therapies in the U.S.

Matt Furlow
August 4th 2020

Several months into the COVID-19 pandemic, this article takes a look back at how the launches of new oncology therapies have been impacted.


Site Logo

EU Medical Device Supply Chains and Trade Agreements: The COVID-19 Response

Andrew Hood and Cliodhna McDonough
August 2nd 2020

Andrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.


Site Logo

Episode 61: Preparing for Virtual High-Stakes Meetings

Elaine Quilici
July 23rd 2020

Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.


Pharm Exec's Top 50 Companies 2020

Pharm Exec's Top 50 Companies 2020

Michael Christel
July 9th 2020

Our 20th annual listing highlights brand surges, new ranking battles, and M&A-sparked upswings, but in the shadow of COVID-19, a peek behind the numbers also tells another story.


Delivering Hope in a Pandemic

Delivering Hope in a Pandemic

Elaine Quilici
June 11th 2020

Pharma is boosting outreach and its image, as the industry faces a defining period in its quest to sway the tide of public perception.


Leading Through a Historical Singularity

Leading Through a Historical Singularity

Arda Ural, PhD
May 28th 2020

Considerations for biopharma to transform itself beyond the COVID-19 crisis, by Arda Ural.


Stephen Frost colour.jpg

Is Pharma Too Introspective to be Truly Innovative?

Stephen Frost
May 14th 2020

Every major pharma company undertakes some form of diversity and inclusion work. However, that doesn’t mean it’s reaching the decision-makers, writes Stephen Frost.

<1
...
91011121314151617
...
19>
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.